Top Markets
#1 ADO Protocol ADO Protocol +193.36%
#2 Islamic Coin Islamic Coin +155.22%
#3 GoPlus Security GoPlus Security +45.23%
#4 Siren Siren +42.82%
#5 GAIB AID GAIB AID +24.80%
#6 Casper Network Casper Network +19.86%
#7 Starpower Starpower +15.89%
#8 Verus Coin Verus Coin +13.74%
#9 o1.exchange o1.exchange +12.92%
#10 Pons Pons +12.30%
Coin of the day
ADO Protocol ADO Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Classifica tra le azioni #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Prezzo delle azioni
$0.5099
Ultima sincronizzazione: 2024-10-15
Capitalizzazione di mercato
$7.60M
Variazione (1 giorno)
2.02%
Variazione (1 anno)
0.00%
Paese
US
Scambia Anew Medical, Inc. (WENA)

Categoria

Healthcare
Rapporto P/B per Anew Medical, Inc. (WENA)
Rapporto P/B al August 2026 TTM: 0.63
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Anew Medical, Inc., il rapporto P/B attuale (TTM) è 0.63. Alla fine del 2022, era pari a 0.79.
Storico del rapporto P/B per Anew Medical, Inc. da 2021 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.63 -87.86%
2023 5.20 561.31%
2022 0.79 -98.96%
2021 75.61 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 904.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 888.33%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 448.09%
BE